期刊文献+

维拉帕米对耐苯妥英钠和卡马西平癫癎模型大鼠电生理和行为的影响 被引量:13

Effect of verapamil on electrobiological activity and seizure behavior in phenytoin-carbamazepine resistant rats
原文传递
导出
摘要 目的观察 P-糖蛋白(PGP)拮抗剂维拉帕米对耐苯妥英钠(PHT)和卡马西平(CBZ)癫癎大鼠电生理指标和行为学的影响。方法建立慢性杏仁核点燃癫癎大鼠模型,筛选出耐药组和治疗有效组,给予维拉帕米,观察其对各组大鼠后放电阈值(after discharge threshold,ADT)、后放电时程(after discharge duration,ADD)等电生理指标和行为学的影响。结果相对于耐药对照组,耐药组大鼠在预先给予维拉帕米后,使用抗癫癎药物后 ADT[(238.0±32.2)μA]明显高于耐药对照组[(177.0±23.3)μA,P<0.05];ADD 时程明显缩短,Racine 行为分级明显下降(P<0.05)。结论维拉帕米可以协助抗癫癎药物(AEDs)改善耐药大鼠的电生理活动,降低点燃后发作分级,提示有效抑制 PGP 有助于改善多药转运体高表达导致的癫癎耐药。 Objective To invesgate the effect of P-glycoprotein (PGP) inhibitor, verapamil, on electrobiological activity and seizure behavior in phenytoin-carbamazepine (PHT-CBZ) resistant rats. Methods The model of medically intractable epilepsy was established by kindling of amygdale. Verapamil was applied to PHT-CBZ resistant rats, followed by the observation on after discharge threshold (ADT), after discharge duration (ADD) and seizure activity. Results Compared with the control group, the ADT was higher in PHT-CBZ resistant rats peritoneally injected with verapamil ( (238.0 ±32. 2) uA vs ( 177. 0 ± 23.3 ) uA, P 〈 0. 05 ) ; verapamil shortened the ADD, reduced the Racine' s behavior degree (P 〈0. 05). Conclusions Specific inhibitors of PGP could improve the electrobiological activity and seizure behavior in PHT-CBZ resistant rats. It is benefit to inhibit PGP for multidrug resistant medically intractable epilepsy.
出处 《中华神经科杂志》 CAS CSCD 北大核心 2007年第3期162-164,共3页 Chinese Journal of Neurology
基金 国家自然科学基金资助项目(30370511) 上海市卫生局青年基金资助项目(034Y04)
关键词 癫痫 P糖蛋白 维拉帕米 抗惊厥药 Epilepsy P-glycoprotein Verapamil Anticonvulsonts
  • 相关文献

参考文献11

  • 1Goddard GV. The kindling model of epilepsy. Trends Neurosci,1983, 6 : 275-279.
  • 2Racine RJ. Modification of seizure activity by electrical stimulation.Ⅱ. Motor seizure. Electroencephalogr Clin Neurophysiol, 1972, 32: 281-294.
  • 3Surgery for epilepsy. Consens Statement, 1990, 8(2) : 1-20.
  • 4Lee G, Dallas S, Hong M, et al. Drug transporters in the central system : brain barriers and brain parenchyma considerations. Pharmacol Rev, 2001, 53: 569-596.
  • 5陈英辉,赵永波,马爱梅,王乃东,呙登俊.难治性癫痫患者脑内MDR1的表达[J].中风与神经疾病杂志,2006,23(1):60-60. 被引量:7
  • 6Rosado C, Cross SE, Pugh WJ, et al. Effect of vehicle pretreatment on the flux, retention, and diffusion of topically applied penetrants in vitro. Pharm Res, 2003, 20: 1502-1507.
  • 7Figueredo A, Arnold A, Goodyear M, et al. Addition of verapamil and tamoxifen to the initial chemotherapy of small cell lung cancer. A phase Ⅰ/Ⅱ study. Cancer, 1990, 65: 1895-1902.
  • 8马爱梅,赵永波,陈英辉.P-糖蛋白对卡马西平和苯妥英钠通过大鼠血脑屏障影响的研究[J].中华神经科杂志,2005,38(7):438-441. 被引量:12
  • 9Mtab DT, Yang JM, Hait WN. Functional role of phosphorylation of the multidrug transporter (P-glycoprotein) by protein kinase C in multidrug-resistant MCF-7 cells. Oncol Res, 1994, 6: 59-70.
  • 10Ranta-Knuuttila T, Kiviluoto T, Mustonen H, et al. Migration of primary cultured rabbit gastric epithelial cells requires intact protein kinase C and Ca^2+/calmodulin activity. Dig Dis Sci,2002, 47:1008-1014.

二级参考文献16

  • 1Fromm MF. P-glycoprotein: a defense mechanism limiting oral bioavailability and CNS accumulation of drugs. Int J Clin Pharmacol Ther, 2000, 38: 69-74.
  • 2Tishler DM, Weinberg KT, Hinton DR, et al. MDR1 gene expression in brain of patients with medically intractable epilepsy.Epilepsia, 1995, 36 : 1-6.
  • 3Sisodiya SM,Lin WR, Harding BN, et al. Drug resistance in epilepsy: expression of drug resistance proteins in common cause of refractory epilepsy. Brain,2002,125:22-31.
  • 4Loscher W, Potschka H. Role of multidrug transporters in pharmacoresistance to antiepileptic drugs. J Phannacol Exp Ther,2002,301:7-14.
  • 5Leveille-Webster CR, Arias IM. The biology of the P-gIycoprotein. J Membr Biol, 1995, 143:89-102.
  • 6Cramer S, Ebert U, Loscher W. Characterization of phenytoin resistant kinded rats, a new model of drug-resistant partial epilepsia:comparision of inbred strains. Epilepsia, 1998, 39: 1046-1053.
  • 7Chikhale EG, Burton PS, Borchardt RT. The effect of verapamil on the transport of pepfid across the blood-brain barrier in rats : kinetic evidence for an apically polarized etllux mechanism. J Pharmacol Exp Ther, 1995, 273 : 298-303.
  • 8Seegers U, Potschka H, Loscher W. Expression of the multidrugtransporter P-glycoprotein in brain capillary endothelial cells and brain parenchyma of amygdala-kindled rats. Epilepsia, 2002, 43:675-684.
  • 9Tishler DM,Weinberg KT,Hinton DR,et al.MDR1 gene expression in brain of patients with medically intractable epilepsy[J].Epilepsia,1995,36 (1):1-6.
  • 10Sisodiya SM,Lin WR,Harding BN,et al.Drug resistance in epilepsy:expression of drug resistance proteins in common cause of refractory epilepsy[J].Brain,2002,125 (1):22-31.

共引文献17

同被引文献133

引证文献13

二级引证文献21

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部